Kallikrein 4 Antikörper (AA 242-254)

Produktnummer ABIN636259

Produktdetails anti-Kallikrein 4 Antikörper

Target: Kallikrein 4 (KLK4) (Kallikrein-Related Peptidase 4 (KLK4))

Bindungsspezifität: AA 242-254

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser Kallikrein 4 Antikörper ist unkonjugiert

Applikation: Western Blotting (WB)

Aufreinigung: Affinity chromatography purified

Immunogen: KLK-L1 antibody was raised in rabbit using AA 242-254 [KFTEWIEKTVQAS] of the human 39 kDa KLK-L1 (KLK4) protein as the immunogen.

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: WB: 1:500-1:1,000
Optimal conditions should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Konzentration: Lot specific

Buffer: Affinity purified IgG supplied in PBS with 0.02 % NaN3.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium Azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Handhabung: Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store at 4 °C for short term storage. Aliquot and store at -20 °C for long term storage.

Details zu Kallikrein 4

Target: Kallikrein 4 (KLK4) (Kallikrein-Related Peptidase 4 (KLK4))

Andere Bezeichnung: KLK-L1 (KLK4 Produkte)

Synonyme: ESMP1 antikoerper, KLK-L1 antikoerper, PSTS antikoerper, Prss17 antikoerper, AI2A1 antikoerper, ARM1 antikoerper, EMSP antikoerper, EMSP1 antikoerper, PRSS17 antikoerper, kallikrein antikoerper, Emsp1 antikoerper, kallikrein related-peptidase 4 (prostase, enamel matrix, prostate) antikoerper, kallikrein related peptidase 4 antikoerper, kallikrein-related peptidase 4 antikoerper, Klk4 antikoerper, KLK4 antikoerper

Hintergrund: Kallikreins are a subgroup of serine proteases and are implicated in carcinogenesis. A novel Kallikrein gene Prostase/KLK-L1 (also known as KLK4) is expressed and is up-regulated by androgens and progestins. KLK-L1 may be involved in the pathogenesis and/or progression of prostate, breast, and possibly other malignancies.

Pathways: Komplementsystem